BRÜGGEMEIER Ulf
No ORCID on file
· 15 papers in corpus
· active 2005
Frequent coauthors
- GEERTS Andreas 15
- GOLZ Stefan 15
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…
2005
The invention provides a human KCNK3 which is associated with the cardiovascular diseases, endocrinological diseases, metabolic diseases, cancer, inflammation, gastro -enterological diseases, hernatological diseases, respiratory diseases, n…